---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-022279"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T02:10:18.032103+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Incannex prices $12.5M private placement at $1.08/share to fund OSA trial

## Summary
- Gross proceeds $12.5M from 11.57M shares at $1.08 plus Series A warrants at $2.16.
- Net proceeds ~$11.3M after placement agent fees and expenses.
- Funds IHL-42X Phase 2/3 OSA study completion and Phase 3 expansion.
- Proceeds also repay outstanding convertible debentures and for working capital.
- Transaction closed March 10, 2025; R.F. Lafferty as sole placement agent.

## SEC filing metadata
- accession: 0001213900-25-022279
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390025022279/0001213900-25-022279-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390025022279/ea0233697-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-022279
- JSON: https://secwatch.observer/filing/0001213900-25-022279.json
- Plain text: https://secwatch.observer/filing/0001213900-25-022279.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.